PAPP-A: a promising therapeutic target for healthy longevity.
about
One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiologyHigh-throughput serum proteomics for the identification of protein biomarkers of mortality in older men.EWS-FLI-1 creates a cell surface microenvironment conducive to IGF signaling by inducing pappalysin-1.Similarity and Variation in the Insulin-like Growth Factor 2 - H19 Locus in Primates.
P2860
PAPP-A: a promising therapeutic target for healthy longevity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PAPP-A: a promising therapeutic target for healthy longevity.
@en
PAPP-A: a promising therapeutic target for healthy longevity.
@nl
type
label
PAPP-A: a promising therapeutic target for healthy longevity.
@en
PAPP-A: a promising therapeutic target for healthy longevity.
@nl
prefLabel
PAPP-A: a promising therapeutic target for healthy longevity.
@en
PAPP-A: a promising therapeutic target for healthy longevity.
@nl
P2860
P356
P1433
P1476
PAPP-A: a promising therapeutic target for healthy longevity
@en
P2093
Cheryl A Conover
P2860
P304
P356
10.1111/ACEL.12564
P50
P577
2016-12-29T00:00:00Z